Shiseido is lining up a ¥13bn corporate-bond issue under a shelf registration that allows up to ¥300bn of issuance through April 24, 2028, turning an April funding framework into a live capital-markets move.
| Feature | Detail |
|---|---|
| Current registration amount | ¥13bn |
| Security type | Corporate bonds |
| Shelf statement filed | April 17, 2026 |
| Shelf effective period | April 25, 2026 to April 24, 2028 |
| Planned shelf amount | ¥300bn |
| Past offerings under shelf | None shown |
| Remaining amount shown on cover page | ¥300bn |
The June 26 supplement says the security type is corporate bonds and fixes the amount for this registration at ¥13bn. The underlying shelf statement was filed on April 17, became effective on April 25 and runs until April 24, 2028. Its planned issuance amount is ¥300bn.
Because this deal sits inside a shelf rather than outside it, the filing shows both the current raise and the wider borrowing envelope around it. The programme has been live only since late April, and the gap between a ¥13bn issue and a ¥300bn ceiling is the part funding watchers will notice first. It tells them Shiseido has set up substantially more headroom than this single sale would use.
The disclosure is also notable for how little of the shelf appears to have been used so far. The past-offerings table shows no previous sales or reductions under the programme, and the cover page still shows a remaining amount of ¥300bn. That is consistent with this supplement being the shelf's first outing, not a follow-on nibble.
The cover page leaves out the fine print credit investors usually ask about first, including coupon, tenor and the intended use of proceeds. So the read-through for now is narrow but useful: Shiseido is using a disclosed debt-raising framework for a modest ¥13bn deal, while keeping a far larger programme in place until April 2028.